Evidence map›Paper›PMID 28064200›Full record

ArticleBlood2017

Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

Suthesh Sivapalaratnam, Sarah K Westbury, Jonathan C Stephens, Daniel Greene, Kate Downes, Anne M Kelly, Claire Lentaigne, William J Astle, Eric G Huizinga, Paquita Nurden and 16 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. AInternational journal of molecular sciences · 2022
    Article
  10. A Novel Mutation inInternational journal of molecular sciences · 2021
    Article
  11. Inherited Platelet Disorders: An Updated Overview.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Structure-function of platelet glycoprotein Ib-IX.Journal of thrombosis and haemostasis : JTH · 2020
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 5 countries.

Suthesh SivapalaratnamDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Sarah K WestburySchool of Clinical Sciences, University of Bristol, Bristol, United Kingdom.ORCID 0000-0002-0950-8148
Jonathan C StephensDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Daniel GreeneDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Kate DownesDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Anne M KellyDepartment of Haematology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.
Claire LentaigneCentre for Haematology, Hammersmith Campus, Imperial College Academic Health Sciences Centre, Imperial College London, London, United Kingdom.
William J AstleDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Eric G HuizingaCrystal and Structural Chemistry, Department of Chemistry, Faculty of Science, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
Paquita NurdenInstitut Hospitalo-Universitaire LIRYC, Hôpital Xavier Arnozan, Pessac, France.
Sofia PapadiaDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Kathelijne PeerlinckDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
Christopher J PenkettDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
David J PerryDepartment of Haematology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Catherine RoughleyKent Haemophilia Thrombosis Centre at East Kent Hospitals University NHS Foundation Trust, Canterbury, United Kingdom.
Ilenia SimeoniDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Kathleen StirrupsDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Daniel P HartDepartment of Haematology, Barts Health National Health Service Trust, London, United Kingdom.
R Campbell TaitDepartment of Haematology, Royal Infirmary, Glasgow, United Kingdom.
Andrew D MumfordSchool of Clinical Sciences, University of Bristol, Bristol, United Kingdom.
NIHR BioResource
Michael A LaffanCentre for Haematology, Hammersmith Campus, Imperial College Academic Health Sciences Centre, Imperial College London, London, United Kingdom.
Kathleen FresonDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.
Willem H OuwehandDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.
Shinji KunishimaDepartment of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Ernest TurroDepartment of Haematology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-1820-6563
National Health Service · GBUniversity of Cambridge · GBUniversity of Bristol · GBEast Kent Hospitals University NHS Foundation Trust · GBElectrophysiology and Heart Modeling Institute · FRGlasgow Royal Infirmary · GBKU Leuven · BEUtrecht University · NL

Funding

British Heart Foundation RG/08/014/24067British Heart Foundation RG/09/012/28096Department of Health RP-PG-0310-1002Medical Research Council MC_UP_0801/1Medical Research Council MC_UU_00002/10Medical Research Council MR/J011711/1Medical Research Council MR/K023489/1Medical Research Council MR/L003120/1Wellcome Trust
6 · The paper itself

Abstract

The von Willebrand receptor complex, which is composed of the glycoproteins Ibα, Ibβ, GPV, and GPIX, plays an essential role in the earliest steps in hemostasis. During the last 4 decades, it has become apparent that loss of function of any 1 of 3 of the genes encoding these glycoproteins (namely, GP1BA, GP1BB, and GP9) leads to autosomal recessive macrothrombocytopenia complicated by bleeding. A small number of variants in GP1BA have been reported to cause a milder and dominant form of macrothrombocytopenia, but only 2 tentative reports exist of such a variant in GP1BB By analyzing data from a collection of more than 1000 genome-sequenced patients with a rare bleeding and/or platelet disorder, we have identified a significant association between rare monoallelic variants in GP1BB and macrothrombocytopenia. To strengthen our findings, we sought further cases in 2 additional collections in the United Kingdom and Japan. Across 18 families exhibiting phenotypes consistent with autosomal dominant inheritance of macrothrombocytopenia, we report on 27 affected cases carrying 1 of 9 rare variants in GP1BB.

Indexed as

MutationAllelesBlood PlateletsCase-Control StudiesFemaleGene ExpressionGenes, DominantGenome, HumanHemorrhageHigh-Throughput Nucleotide SequencingHumansMalePedigreePlatelet CountPlatelet Glycoprotein GPIb-IX ComplexThrombocytopeniaadhesion receptorPlatelet Glycoprotein GPIb-IX Complex

Identifiers

PMID28064200
PMCPMC6037295
OpenAlexW2551158345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.